1929
DOI: 10.1038/icb.1929.21
|View full text |Cite
|
Sign up to set email alerts
|

Studies in the Reaction of Urine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
4
0

Year Published

1932
1932
1995
1995

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 7 publications
2
4
0
Order By: Relevance
“…The T cell activation and associated proteins (TAP and TPAa) recognized by these monoclonals were recently shown also to be controlled by genes linked to the Ly-6 locus . Similar transmembrane signalling effects have been noted with monoclonal antibodies specific for Thy-i and the mouse and human T cell receptor and the associated human T3 complex proteins (Gunter et al, 1984;Kaye and Janeway, 1984;Meuer et al, 1984). Biochemical characterization of Ly6C.2 (Takei, 1982), Ly-6E.1 and TAP/TAPa have shown them to be small proteins with Mr 15 000-18 000, apparently distinct from presently described mouse T cell receptor-associated proteins and Thy-I (Campbell et al, 1981;Allison and Lanier, 1985;Samelson et al, 1985a;Oettgen et al, 1986).…”
Section: Introductionsupporting
confidence: 61%
“…The T cell activation and associated proteins (TAP and TPAa) recognized by these monoclonals were recently shown also to be controlled by genes linked to the Ly-6 locus . Similar transmembrane signalling effects have been noted with monoclonal antibodies specific for Thy-i and the mouse and human T cell receptor and the associated human T3 complex proteins (Gunter et al, 1984;Kaye and Janeway, 1984;Meuer et al, 1984). Biochemical characterization of Ly6C.2 (Takei, 1982), Ly-6E.1 and TAP/TAPa have shown them to be small proteins with Mr 15 000-18 000, apparently distinct from presently described mouse T cell receptor-associated proteins and Thy-I (Campbell et al, 1981;Allison and Lanier, 1985;Samelson et al, 1985a;Oettgen et al, 1986).…”
Section: Introductionsupporting
confidence: 61%
“…Antibodies, plasmids and other reagents The following monoclonal antibodies were used: 3D3 (anti-D1O TCR, mouse IgGI) (Kaye et al, 1983); C193.5A (anti-D1O TCR, mouse IgGI) (Tite et al, 1986a); F23.1 (anti-Vf38. 1, mouse IgG2a) (Staerz et al, 1985); YCD3-1 (anti-mouse CD3e, rat IgG2c) (Portolds et al, 1989a); GK1.5 (antimouse CD4, rat IgG2b) (Dialynas et al, 1983); YT4.2 (anti-mouse CD4, rat IgG2a) (Janeway Jr et al, 1987); M17/5 (anti-CD lla, rat IgG2a) (Sanchez-Madrid et al, 1982); M1/70 (anti-CDlIb, rat IgG2b) (Springer et al, 1979); M1/9.3 (pan-CD45, rat IgG2a) (Coffman, 1982); and Y-19 (anti-Thy-i, rat IgG) (Jones and Janeway, 1981) were obtained from Dr Charles A.Janeway Jr, Yale University School of Medicine, New Haven, CT. All antibodies were purified from hybridoma supematants by affinity chromatography over protein A -Sepharose columns (Pharmacia).…”
Section: Methodsmentioning
confidence: 99%
“…It was maintained by stimulation every 2 weeks at 5 x 104 cells/ml with mitomycin-C treated H-2k (C3H) spleen cells (5 x 104 cells/ml) plus antigen (100 ug/ml conalbumin) in Click's medium supplemented with 10% inactivated fetal calf serum (culture medium). D10.G4.1 (Kaye et al, 1983) was maintained as described for SR.D10 except that 105 responder cells/mil and 106 spleen cells/mil were used. The I-Ak transfected TAK lymphoma (Buerstedde et al, 1988) was obtained from Dr Charles A.Janeway, Jr. CD4+ T lymphocytes were obtained from spleen cell suspensions of C3H mice.…”
Section: Methodsmentioning
confidence: 99%
“…The recipients used for transfection were resting D10.G4.1 cells (10-14 days post-antigen stimulation), a murine TH2 clone with specificity for conalbumin on H2Ak (Kaye et al, 1983) and 58a-pcells, a T cell hybridoma lacking an a[B receptor (Letoumeur and Malissen, 1989).…”
Section: Transfection and Cell Culturementioning
confidence: 99%